Profit from Panic: 3 Top Contrarian Stocks to Buy Now

Hunting for a bargain? This group of beaten-down stocks, including Bausch Health Companies (TSX:BHC)(NYSE:BHC), might provide the value you’re looking for.

| More on:
edit Woman calculating figures next to a laptop

Image source: Getty Images.

Hi there, Fools. I’m back to highlight three stocks that fell sharply last week. As a quick reminder, I do this because great wealth is built by buying quality companies: during periods of extreme pessimism; when professional analysts are turning away from them; and when they’re available at a discount to intrinsic value.

As the great Warren Buffett once warned, “You pay a very high price in the stock market for a cheery consensus.”

So, without further ado, let’s get to it.

Car wreck

Leading off our list is auto parts company Uni-Select (TSX:UNS), whose shares plunged a whopping 35% last week.

Most of the damage was done on Wednesday, when the company posted disappointing Q4 results. During the quarter, adjusted EPS and EBITDA came in well below expectations on revenue growth of just 1%. Moreover, the company’s 2019 guidance — organic sales growth of 1.25%-3.25% and EBITDA margin of 5.75%-6.75% — also missed estimates.

Management is continuing with a strategic review to address its ongoing challenges. Uni-Select also has a leveraged balance sheet, so the stock isn’t for the fainthearted.

That said, with the shares now off 50% from their 52-week highs and trading at a cheapish forward P/E of 11, now might be a good time for enterprising investors to take a look.

Real estate slump

Next up we have real estate services company Altus Group (TSX:AIF), which is down 7% over the past week.

The big drop came on Friday after the company’s weaker-than-expected Q4 results: earnings fell 13% to $55 million as revenue improved just 6%. Adjusted operating margin also declined significantly on reinvestments, thereby suggesting that Altus’ competitive edge is becoming more expensive to maintain.

That said, management remains bullish.

Altus CEO Robert Courteau said, “2018 was a very productive year as we further expanded our Altus Analytics business into Europe and Asia, added sales to larger, enterprise deals with a higher mix of recurring revenues, and increased the market share of our Property Tax business.”

After the pullback, Altus shares are off 27% from their 52-week highs and offer a decent yield of 2.5%.

Healthy value

Rounding out our list is pharmaceutical company Bausch Health Companies (TSX:BHC)(NYSE:BHC), whose shares sank 8% last week.

Bay Street wasn’t thrilled with Bausch’s Q4 results. During the quarter, the company posted a loss of $350 million as revenue declined 1.9% to $2.12 billion. Bausch’s full-year 2019 guidance — non-GAAP EBITDA of $3.35-$3.5 billion on revenue of $8.3-$8.5 billion — also failed to impress investors.

On the (very) bright side, Bausch’s organic revenue continues to grow steadily while its debt load continues to decline, suggesting that management’s turnaround efforts are progressing nicely.

“2018 was a strong year for Bausch Health as we delivered organic revenue growth across the entire Company while reducing our total debt by more than $1 billion and strategically investing in our core businesses,” said Chairman and CEO Joseph Papa.

Bausch shares are now off about 15% from their 52-week highs.

The bottom line

There you have it, Fools: three slumping stocks worth checking out.

As always, they aren’t formal recommendations. Just view them as a starting point for further research. Plunging stocks can keep plunging for a prolonged period of time, so plenty of your own homework is required.

Fool on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of Bausch Health Companies.

More on Investing

Senior Couple Walking With Pet Bulldog In Countryside
Dividend Stocks

CPP Insights: The Average Benefit at Age 60 in 2024

The average CPP benefit at age 60 in average is low, but claiming early has many advantages with the right…

Read more »

edit Sale sign, value, discount
Investing

2 Bargains I’d Buy as They Dip Toward 52-Week Lows

Spin Master (TSX:TOY) stock and another underrated Canadian play could surge again as they look to reverse course.

Read more »

thinking
Dividend Stocks

Why Did goeasy Stock Jump 6% This Week?

The spring budget came in from our federal government, and goeasy stock (TSX:GSY) investors were incredibly pleased by the results.

Read more »

woman analyze data
Dividend Stocks

My Top 5 Dividend Stocks for Passive-Income Investors to Buy in April 2024

These five TSX dividend stocks can help you create a passive stream of dividend income for life. Let's see why.

Read more »

investment research
Stocks for Beginners

New Investors: 5 Top Canadian Stocks for 2024

Here are five Canadian stocks that might be ideal for a beginner investment portfolio.

Read more »

Pipeline
Energy Stocks

Here Is Why Enbridge Is a No-Brainer Dividend Stock

For investors looking for a no-brainer dividend stock worth holding for the long term, here's why Enbridge (TSX:ENB) should be…

Read more »

Dots over the earth connecting the world
Tech Stocks

Hot Takeaway: Concentration in 1 Stock Can Be Just Fine

Concentration in one stock can be alright under the right circumstances, and far better than buying a bunch of poor-performing…

Read more »

grow money, wealth build
Bank Stocks

TD Bank Stock Got Upgraded, and It’s a Good Time to Load Up

TD Bank (TSX:TD) stock is getting too cheap, even for analysts at the competing banks!

Read more »